A Safety and Tolerability Study of REGN88(SAR153191) in Subjects With Rheumatoid Arthritis
Clinical trial NCT01026519 · COMPLETED
Trial details
- NCT number
- NCT01026519
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-09-01
- Primary completion
- 2009-03-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.